The immunoblotting validation of 54 CCA bile samples showed a positive rate of 70% for AAT in CCA diagnosis, and AAT also remarkable increased in the tissues and stool of CCA patients, suggesting that bile AAT is one of possible biomarkers for diagnosing CCA [118]. The gene discussed is SERPINA1; the disease is cholangiocarcinoma.